Jiyoung Kim, PhD Seoul National University

Slides:



Advertisements
Similar presentations
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Lockhart BP, Lestage PJ. January 2003.
Advertisements

Growth Factor (GF) Cascades and exercise and the regulation of cognition, mood and motor control: Are GFs a common mechanism? Carl W. Cotman Director,
Alzheimer’s Disease Edwin Onattu P. 3.
Question: What do we know about the elusive nature of the pathogenesis of Alzheimer's disease? How can personalized medicine, or the application of genomics.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
Tracie Wymer Julie Franks Shirin Malek Inflammatory Diseases.
Chronic Nicotine Restores Normal Aβ Levels and Prevents Short-term Memory and E-LTP Impairment in Aβ Rat Model of Alzheimer’s Disease Marisa Srivareerat,
BIOMEDICALRESEARCH. What is biomedical research?  Definition: Biomedical research is the broad area of science that looks for ways to prevent and treat.
Spatial Memory & Navigation Objectives: 1. To introduce spatial performance as a topic in psychological science 2. To illustrate how diverse psychological.
The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. Susan A. Farr, et al.
Risk of Developing Alzheimer’s Disease in Persons with MCI
Decision presented by the committee board members: Nicholas Mann & Katelyn Strasser FUTURE FUNDING FOR ALZHEIMER’S DISEASE October 14, 2014 MPH 543 Leadership.
Pharmacological Management. Only symptomatic treatment, there is no cure. Acetylcholinesterase inhibitors - Only for mild to moderate dementia –Donepezil.
The use of Pan-PPAR Agonists for Treatment of Tauopathies and Huntington’s disease Inventor: Flint Beal, MD Chairman of Neurology and Neuroscience/Neurologist-in-Chief.
Alzheimer’s Society, UK Our research programme
COST CM1103 Training School Structure-based drug design for diagnosis and treatment of neurological diseases Istanbul, 9-13 Sept 2013 Mirjana Babić, mag.biol.mol.
Medical University of Sofia, Faculty of Medicine Department of Pharmacology and Toxicology Alzheimer’s Disease Avi Gandhi (2009)
COLUMBIA PRESBYTARIAN HOSPITAL CENTER
Detecting Individual Differences in Changes in Memory Functioning Dr. Len Lecci Professor of Psychology University of North Carolina Wilmington Director.
D ISTINCT C OMPONENTS OF S PATIAL L EARNING R EVEALED BY P RIOR T RAINING AND NMDA R ECEPTOR B LOCKADE Group B3 Abdullah, Barbara, Charles, Charmaine,
Effects of matrix metalloproteinase-9 on insulin survival pathways in Alzheimer’s disease Introduction Defective brain insulin signaling has been suggested.
Contemporary Science Issues Lesson 6: New medicines Task 1: Testing and using a new drug Timeline cards (4 per A4 page) In pairs, students are required.
Geula & Mesulam, Cerebral Cortex 1996, 6: Age-matched controlAlzheimer’s disease.
Early Intervention in Dementia Bernie Coope Consultant Old Age Psychiatrist/Associate Medical Director/Honorary Senior Lecturer, Worcester Association.
Norton-scientificcollection.com/collection. HEALTH NEWS Bapineuzumab, the treatment being developed by Elan, Johnson & Johnson and Pfizer for Alzheimer’s.
Alzheimer Disease Dementia: an acquired, generalized, and often progressive impairment of cognitive function that affects the content, but not the level.
DEMENTIA 1/6/16 DR TONY O’BRIEN MD FRCP. Dementia Common – 700,000 sufferers in the UK Common – 700,000 sufferers in the UK Prevalence increases with.
Camara M1, Anscomb H.L. 2 and Baune B.T. 1,2
Hadley KEY SLIDES 9-5 7:45-8:15 PM
A journey through drug discovery The life cycle of a new medicine
Faezeh Tashakori Sabzevar
Ying Cheng (1st-year PhD), supervised by Dr Gayle Doherty
Designing drugs for neuroprotection
BEHAVIOR AND MEMORY EVALUATION OF RATS TREATED WITH SIMVASTATIN IN THE SCOPOLAMINE ANIMAL MODEL TONIN, F. S.; BARBIERO, J. K. Departamento de Farmacologia,
Possible new treatments for Congenital Hyperinsulinism
Seizures in Alzheimer’s disease
Alzheimer Disease Dementia: an acquired, generalized, and often progressive impairment of cognitive function that affects the content, but not the level.
BIOMEDICAL RESEARCH.
Progress Report U Aims 1 & 2: To test L-NAP and other compounds for therapeutic potential in preventing alcohol-induced damage to the cerebellum.
Alzheimer Disease Dementia: an acquired, generalized, and often progressive impairment of cognitive function that affects the content, but not the level.
Synergistic Memory Impairment Through the Interaction of Chronic Cerebral Hypoperfusion and Amlyloid Toxicity in a Rat Model by Bo-Ryoung Choi, Sang Rim.
Alzheimer’s Disease Medical University of Sofia, Faculty of Medicine
Need laboratory experience??
Curcumin Requires Tumor Necrosis Factor α Signaling to Alleviate Cognitive Impairment Elicited by Lipopolysaccharide Neurosignals 2013;21: DOI: /
Frontotemporal Dementia
the rat entorhinal cortex Croatian Science Foundation
Pille Link, Prof. Dr. M. Wink University of Heidelberg
Nat. Rev. Neurol. doi: /nrneurol
Reisa Sperling, Elizabeth Mormino, Keith Johnson  Neuron 
Xenon: no stranger to anaesthesia
Methods Objectives Results Conclusions References
Probing the Biology of Alzheimer's Disease in Mice
Figure 3 VEGF in neurodegenerative disease
Volume 15, Issue 9, Pages (May 2016)
Alzheimer's.
Volume 11, Issue 2, Pages (April 2015)
Alzheimer’s Disease Neurobiology
Are ageing and age-related diseases treatable?
Hello, my name is Attakias and today I will be presenting a study on…
Hippocampus? OR....
Stem cell Basics.
Neuronal ATM level is reduced in mouse models of AD
CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease  Fang Huang, Minghui Wang, Rong Liu, Jian-Zhi Wang, Eric Schadt, Vahram.
Figure 4 Prevention of onset of behavioral deficits following 3-month treatment of Baxter IG in Dutch APP E693Q transgenic mice Prevention of onset of.
 Conceptual diagram of acetylcholine system and disease and drug effects.  Conceptual diagram of acetylcholine system and disease and drug effects. Relative.
Antitumor effects of celastrol in vitro and in vivo.
Pdcd4 expression inhibits AP-1 transactivation.
Tumor protection induced by therapeutic PLG vaccination in combination with blockade antibodies. Tumor protection induced by therapeutic PLG vaccination.
Fig. 1. APP/PS1;C3 KO mice show improved cognitive flexibility (reversal) compared to APP/PS1 mice at 16 months of age. APP/PS1;C3 KO mice show improved.
Presentation transcript:

Jiyoung Kim, PhD Seoul National University 3rd World Congress on Pharmacology Birmingham, UK 2016. 08. 09 Sulforaphane prevents cholinergic deficits and cognitive impairment in mice Hello, everyone. It is a pleasure to be here with all of you today. Having the opportunity to do this presentation is indeed an honor. I hope that I become a strong candidate for the position which your college is looking for. I hope that I will have the opportunity to develop my research further at your university in the coming years. Moreover, I would like to contribute to the research at the college of pharmacy, Korea University so that the program as well as the student in this program become more advanced to promote the knowledge of this field throughout the world, making a meaningful and lasting change. There was evidence… Jiyoung Kim, PhD Seoul National University

Preventive Medicine The quotation advices us that preventing diseases is important / The quotation advices us that the prevention of diseases is important How important prevention is… Before the disease occurs…

Science 2012 How important prevention is… Despite intensive laboratory and clinical research over three decades, an effective treatment to delay the onset and progression of Alzheimer's disease is not at hand. Recent clinical trial failures suggest that we must treat the disease earlier than in its mild to moderate stages.

c Scientific American Mind 2016 March/April

Cruciferous Vegetables: Plants Containing Sulforaphane Sulforaphane is an organosulfur compound found in cruciferous plants broccoli sprouts broccoli purple cabbages cabbages brussels sprouts cauliflower kohlrabi bok choy kale etc.

Anti-Dementia Effects of Sulforaphane Sulforaphane (1-isothiocyanato-4-methylsulfinylbutane) - a strong Nrf2 activity inducer - first attracted interest because of its potential anti-cancer activity - recent in vitro and in vivo studies have examined the potential neuroprotective actions the potential effects of sulforaphane on cognitive function have not yet been elucidated

Scopolamine-Induced Memory Impairment Animal Model Scopolamine-Induced Memory Impairment c Alzheimer’s disease - Muscarinic cholinergic receptor ↓ - Acetylcholine ↓ Scopolamine - Muscarinic cholinergic blockade - Acetylcholinesterase activity ↑ - Cholinergic hypofunction Scopolamine has been used as a standard / reference drug for inducing cognitive deficits in healthy humans and animals (Bartus RT et al. Science, 1982) Scopolamine 동물실험 모델 - 일시적 기억장애를 일으키는 물질인 scopolamine (muscarinic antagonist)을 이용하여 일시적 장애를 일으킨 후 시험하고자 하는 sample이 효능이 있는지 여부를 확인하는 실험모델

Behavioral test - Water maze test Start Start Start Start The water maze is commonly used to assay spatial cognition, or, more generally, learning and memory in experimental rodent models. Spatial learning is then typically assessed in a probe test, where the platform is removed from the pool and the mouse or rat is allowed to search for it.

Sulforaphane Inhibits Scopolamine-Induced Memory Impairment Kim J et al. Pharm Res, 2014 How long it takes to find the platform… We measured the distance traveled … still takes a long time…

Sulforaphane Protects Cholinergic System Kim J et al. Pharm Res, 2014 … keeps the level of … high.

Sulforaphane Inhibits Acetylcholinesterase Activity Cell-free effect of sulforaphane on acetylcholinesterase (AChE) activity. Percentage of AChE activity inhibition by sulforaphane (SFN, 0, 1.25, 2.5, 5, 10, 20, 40,80, 160, 320, or 640 mM). Data are presented as mean ± SEM (n = 6). The IC50 value was calculated by means of regression analysis.

Kim J et al. Pharm Res, 2014

Triple Transgenic (APP-PS1-Tau) Alzheimer’s Disease Mouse Model WT 3XTg 17 M 10 M 15 M pTau pTau pTau WT 3Xtg 11 M 17 M 10 M 15 M APP Scopolamine 동물실험 모델 - 일시적 기억장애를 일으키는 물질인 scopolamine (muscarinic antagonist)을 이용하여 일시적 장애를 일으킨 후 시험하고자 하는 sample이 효능이 있는지 여부를 확인하는 실험모델 Amyloid β Amyloid β Amyloid β pTau Amyloid β GAPDH

Triple Transgenic (APP-PS1-Tau) Alzheimer’s Disease Mouse Model These mouse have the learning and memory deficits at the age of 6 month.

Acknowledgements Graduate Students Siyoung Lee Jisung Kim Seoul National University Prof. Ki Won Lee Konkuk University Bo-Ryoung Choi Prof. Jung-Soo Han Grant NRF-2012R1A1A3011954 NRF-2015R1A1A3A04000963 Thank you for your attention. If you have any questions or comments, please feel free to share them with me. MAP2(Green)-positive primary cortical neurons cultured by Jiyoung Kim